Rani Therapeutics to Participate in September Investor Conferences
Rani Therapeutics (Nasdaq: RANI), a clinical-stage biotherapeutics company focusing on oral delivery of biologics and drugs, has announced its participation in two major investor conferences in September 2024. The company will be present at the H.C. Wainwright 26th Annual Global Investment Conference on September 10 and the 2024 Cantor Global Healthcare Conference on September 18, both in New York City.
CEO Talat Imran will represent Rani at both events, delivering a company presentation at the H.C. Wainwright conference and participating in a fireside chat at the Cantor conference. Both events will also include one-on-one investor meetings. Interested parties can access live webcasts of these presentations through the 'Events' section of Rani Therapeutics' website, with replays available after the events conclude.
Rani Therapeutics (Nasdaq: RANI), un'azienda biofarmaceutica in fase clinica specializzata nella somministrazione orale di biologici e farmaci, ha annunciato la sua partecipazione a due importanti conferenze per investitori a settembre 2024. L'azienda sarà presente al 26° Congresso Annuale Globale sugli Investimenti H.C. Wainwright il 10 settembre e al Congresso Globale sulla Salute Cantor 2024 il 18 settembre, entrambi a New York City.
Il CEO Talat Imran rappresenterà Rani a entrambi gli eventi, presentando l'azienda alla conferenza H.C. Wainwright e partecipando a una conversazione informale alla conferenza Cantor. Entrambi gli eventi includeranno anche incontri individuali con gli investitori. Le parti interessate possono accedere a webcast dal vivo di queste presentazioni attraverso la sezione 'Eventi' del sito web di Rani Therapeutics, con riproduzioni disponibili dopo la conclusione degli eventi.
Rani Therapeutics (Nasdaq: RANI), una empresa bioterapéutica en etapa clínica que se centra en la entrega oral de biológicos y fármacos, ha anunciado su participación en dos importantes conferencias para inversionistas en septiembre de 2024. La empresa estará presente en la 26ª Conferencia Anual Global de Inversiones H.C. Wainwright el 10 de septiembre y en la Conferencia Global de Salud Cantor 2024 el 18 de septiembre, ambas en la ciudad de Nueva York.
El CEO Talat Imran representará a Rani en ambos eventos, presentando la empresa en la conferencia de H.C. Wainwright y participando en una conversación informal en la conferencia Cantor. Ambos eventos también incluirán reuniones individuales con inversionistas. Las partes interesadas pueden acceder a transmisiones en vivo de estas presentaciones a través de la sección 'Eventos' del sitio web de Rani Therapeutics, con repeticiones disponibles después de que concluyan los eventos.
Rani Therapeutics (Nasdaq: RANI)는 생물학적 제제 및 약물의 경구 전달을 중심으로 하는 임상 단계의 생물치료제 회사로, 2024년 9월 두 개의 주요 투자자 회의에 참여할 것임을 발표했습니다. 이 회사는 9월 10일 H.C. Wainwright 제26회 연례 글로벌 투자 회의와 9월 18일 2024 Cantor 글로벌 헬스케어 회의에 모두 뉴욕에서 참석할 예정입니다.
CEO Talat Imran은 두 행사에서 Rani를 대표하며, H.C. Wainwright 회의에서는 회사 발표를 하고, Cantor 회의에서는 대화 편에 참여할 예정입니다. 두 행사 모두 일대일 투자자 미팅도 포함될 것입니다. 관심 있는 당사자는 Rani Therapeutics 웹사이트의 '이벤트' 섹션을 통해 이러한 발표의 실시간 웹 방송에 접속할 수 있으며, 행사 종료 후 재생도 가능합니다.
Rani Therapeutics (Nasdaq: RANI), une entreprise biopharmaceutique en phase clinique axée sur la délivrance orale de produits biologiques et de médicaments, a annoncé sa participation à deux grandes conférences pour investisseurs en septembre 2024. L'entreprise sera présente à la 26ème Conférence Annuelle Mondiale d'Investissement H.C. Wainwright le 10 septembre et à la Conférence Mondiale de Santé Cantor 2024 le 18 septembre, toutes deux à New York.
Le PDG Talat Imran représentera Rani lors des deux événements, présentant l'entreprise lors de la conférence H.C. Wainwright et participant à une discussion informelle lors de la conférence Cantor. Les deux événements incluront également des réunions individuelles avec les investisseurs. Les parties intéressées peuvent accéder aux webcasts en direct de ces présentations via la section 'Événements' du site Web de Rani Therapeutics, avec des replays disponibles après la fin des événements.
Rani Therapeutics (Nasdaq: RANI), ein biopharmazeutisches Unternehmen in der klinischen Phase, das sich auf die orale Verabreichung von Biologika und Medikamenten konzentriert, hat seine Teilnahme an zwei wichtigen Investorenkonferenzen im September 2024 bekannt gegeben. Das Unternehmen wird am 26. jährlichen globalen Investorenkonferenz von H.C. Wainwright am 10. September und an der 2024 Cantor Global Healthcare Conference am 18. September, beide in New York City, teilnehmen.
CEO Talat Imran wird Rani bei beiden Veranstaltungen vertreten, eine Unternehmenspräsentation auf der H.C. Wainwright-Konferenz halten und an einem informellen Gespräch auf der Cantor-Konferenz teilnehmen. Beide Veranstaltungen werden auch Einzelgespräche mit Investoren umfassen. Interessierte Parteien können über den Bereich 'Veranstaltungen' auf der Website von Rani Therapeutics auf Live-Webcasts dieser Präsentationen zugreifen, wobei Wiederholungen nach Abschluss der Veranstaltungen verfügbar sind.
- None.
- None.
SAN JOSE, Calif., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral delivery of biologics and drugs, today announced that the Company will participate in two upcoming investor conferences in September 2024. These conferences include:
H.C. Wainwright 26th Annual Global Investment Conference
Location: Lotte New York Palace Hotel, New York, NY
Date: Tuesday, September 10, 2024 at 4:30 pm E.T.
Format: Company Presentation and 1x1 Investor Meetings
Presenter: Chief Executive Officer, Talat Imran
2024 Cantor Global Healthcare Conference
Location: InterContinental Barclay Hotel, New York, NY
Date: Wednesday, September 18, 2024 at 11:30am E.T.
Format: Fireside Chat and 1x1 Investor Meetings
Presenter: Chief Executive Officer, Talat Imran
Interested parties can register for and access the live webcasts for these conferences by visiting the “Events” section of the Rani Therapeutics website. The webcast replays will be available after the conclusion of the respective presentations.
About Rani Therapeutics
Rani Therapeutics is a clinical-stage biotherapeutics company focused on advancing technologies to enable the development of orally administered biologics and drugs. Rani has developed the RaniPill® capsule, which is a novel, proprietary and patented platform technology, intended to replace subcutaneous injection or intravenous infusion of biologics and drugs with oral dosing. Rani has successfully conducted several preclinical and clinical studies to evaluate safety, tolerability and bioavailability using RaniPill® capsule technology. For more information, visit ranitherapeutics.com.
Investor Contact:
investors@ranitherapeutics.com
Media Contact:
media@ranitherapeutics.com
FAQ
What investor conferences will Rani Therapeutics (RANI) attend in September 2024?
Who will represent Rani Therapeutics (RANI) at the September 2024 investor conferences?
What type of presentations will Rani Therapeutics (RANI) give at the September 2024 conferences?
How can investors access Rani Therapeutics' (RANI) presentations at the September 2024 conferences?
